Discontinuation report HP-PAC

Last updated on 2021-03-09 History
Report ID 118321
Drug Identification Number 02238525
Brand name HP-PAC
Common or Proper name AMOXICILLIN, LANSOPRAZOLE, CLARITHROMYCIN
Company Name TAKEDA PHARMACEUTICALS AMERICA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LANSOPRAZOLE AMOXICILLIN CLARITHROMYCIN
Strength(s) 30MG 500MG 500MG
Dosage form(s) KIT CAPSULE TABLET CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size HP PAC 7 DAY THERAPY
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-03-08
Remaining supply date 2020-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Product Expired June 30, 2020. No remaining supply.
Company comments Product discontinued for business reason.
Health Canada comments
Tier 3 Status No
Contact Address 95 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS
UNITED STATES 02421
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-03-09 French Compare
v9 2021-03-09 English Compare
v8 2020-06-18 English Compare
v7 2020-06-18 English Compare
v6 2020-06-18 English Compare
v5 2020-06-18 English Compare
v4 2020-06-18 English Compare
v3 2020-06-18 English Compare
v2 2020-06-18 English Compare
v1 2020-06-18 English Compare

Showing 1 to 10 of 10